2004
DOI: 10.1111/j.1365-2559.2004.01784.x
|View full text |Cite
|
Sign up to set email alerts
|

Aberrant neurofilament protein and synaptophysin expression in malignant melanoma of the nasal cavity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

5
22
1

Year Published

2011
2011
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(28 citation statements)
references
References 13 publications
5
22
1
Order By: Relevance
“…Published reports documented a variable degree of labeling with S-100 in SNM, ranging from 86% to 100%. 2,11,[15][16][17] However, in our study, all 5 cases showed negative or focal scattered staining for S-100. The small cells were almost negative for S-100 although pleomorphic cells in the same tumor with mixed pattern gave strong positive reactions.…”
Section: Discussioncontrasting
confidence: 58%
See 3 more Smart Citations
“…Published reports documented a variable degree of labeling with S-100 in SNM, ranging from 86% to 100%. 2,11,[15][16][17] However, in our study, all 5 cases showed negative or focal scattered staining for S-100. The small cells were almost negative for S-100 although pleomorphic cells in the same tumor with mixed pattern gave strong positive reactions.…”
Section: Discussioncontrasting
confidence: 58%
“…8,14 About 80% of SNM arise in the nasal cavity with septum and inferior turbinate being the most commonly involved sites. 3,7,11 It is rare in the middle turbinate, and there are no case reports of SNM from the superior turbinate or olfactory recess. 3 In general, frequent local recurrences after surgical resection and distant metastases of SNM portend a grave prognosis.…”
Section: Discussionmentioning
confidence: 96%
See 2 more Smart Citations
“…5 It is less widely appreciated that melanomas too may show aberrant expression of various immunohistochemical markers, with a relatively small number of reports, of melanomas showing expression of intermediate filaments other than vimentin (e.g., keratins, desmin, neurofilament protein, and glial fibrillary acidic protein) [6][7][8] and/or neuroendocrine markers. [9][10][11] Over the past several years, we have seen in consultation a significant number of melanomas in which aberrant expression of intermediate filaments and/or neuroendocrine markers obscured the correct diagnosis, and prompted consideration of various non-melanocytic neoplasms, including carcinoma, rhabdomyosarcoma, neural neoplasms, and various neuroendocrine tumors. As no study to date appears to have comprehensively examined this issue, we evaluated a large number of well-characterized melanomas, using contemporary immunohistochemical techniques, to better determine the actual frequency of aberrant expression of these markers.…”
mentioning
confidence: 99%